Evidera
Joanna Kamar, MPH, is a research professional specializing in evidence synthesis, health economics, and market access, currently serving as Research Associate II and Project Manager at Evidera since May 2022. Joanna's expertise includes proposal development, protocol design, and conducting systematic literature searches, while effectively coordinating project timelines and deliverables. Previous roles include Associate Research Scientist at PRECISIONheor, where Joanna focused on systematic reviews, and Research Associate at McGill University, conducting comprehensive research on AI in healthcare. Additional experience includes medical writing at IC Axon, research assistance at the McGill Centre for the Convergence of Health and Economics, and health promotion at Johns Hopkins Aramco Healthcare. Joanna holds a Master of Public Health from King's College London and a Bachelor of Science in Food Science and Nutrition from Carleton University.
This person is not in any teams
This person is not in any offices
Evidera
1 followers
Evidera is a business within Pharmaceutical Product Development, LLC, (PPD) a leading global contract research organization (CRO), and is the preeminent provider of evidence-based solutions to demonstrate the real-world effectiveness, safety, and value of biopharmaceutical and biotechnology products from early development through loss of exclusivity. We provide integrated scientific expertise and global operational capabilities to help you generate the evidence needed to optimize the market access and commercial potential of your products. Evidera was acquired by PPD in 2016 and originally created in 2013 as an independent company under the ownership of Symphony Technology Group following the acquisition of long-standing health economics, outcomes research, market access, epidemiology, and data analytics practices from United BioSource Corporation (UBC). Evidera has over 30 years of leadership and experience and its legacy brands include MEDTAP, Caro Research, Abt Bio-Pharmaceutical Solutions, MetaWorks, Total Healthcare Group, and Archimedes.